Ligase-mediated programmable genomic integration (L-PGI)
Authors:
Open Access
- 10 December 2025
- journal article
- research article
- Published by Springer Nature in Nature Communications
- Vol. 17 (1)
Abstract
Since their discovery, CRISPR systems have been repurposed for programmable targeted genomic editing, leading to applications for gene disruption, single base editing, insertion, deletion, and manipulation of short genomic sequences. Pairing Cas9 nickase with reverse transcriptase allows applications for insertion, substitution, and deletion of short genomic sequences from an RNA template without generating double stranded breaks however this technology typically shows reduced efficacy in post mitotic cells, limiting its translatability in vivo. Here we present a novel, ligase-based method that addresses these limiations. We introduce edits through delivery and ligation of a synthetic DNA donor to genomic nicks created with Cas9 nickase and report editing activity in cell lines, primary cell cultures, and adult mice via nonviral delivery. With favorable on target outcomes compared to transcription-based editing in key cell types, good tolerability, and deliverability, ligation-mediated gene editing has the potential to further advance genomic medicine.Keywords
This publication has 40 references indexed in Scilit:
- Phage-assisted evolution and protein engineering yield compact, efficient prime editorsCell, 2023
- Prime editing: advances and therapeutic applicationsTrends in Biotechnology, 2023
- Leveraging knowledge of HDLs major protein ApoA1: Structure, function, mutations, and potential therapeuticsBiomedicine & Pharmacotherapy, 2022
- Enhanced prime editing systems by manipulating cellular determinants of editing outcomesCell, 2021
- A review of cystic fibrosis: Basic and clinical aspectsAnimal Models and Experimental Medicine, 2021
- 30 years of repeat expansion disorders: What have we learned and what are the remaining challenges?The American Journal of Human Genetics, 2021
- AAV-Mediated CRISPR/Cas9 Gene Editing in Murine PhenylketonuriaMolecular Therapy - Methods & Clinical Development, 2020
- Locked nucleic acid: modality, diversity, and drug discoveryDrug Discovery Today, 2018
- Expanded GGGGCC Hexanucleotide Repeat in Noncoding Region of C9ORF72 Causes Chromosome 9p-Linked FTD and ALSNeuron, 2011
- A Hexanucleotide Repeat Expansion in C9ORF72 Is the Cause of Chromosome 9p21-Linked ALS-FTDNeuron, 2011